Phenotypic Suppression by Aminoglycoside Antibiotics of Mutations Blocking Erythromycin Biosynthesis in Saccharopolyspora erythraea
AUTOR(ES)
Lewandowska-Skarbek, Marlena
RESUMO
The presence of a sublethal amount of apramycin, the aminoglycoside antibiotic used as a selectable marker in transformations of Saccharopolyspora erythraea with pKC505 and related plasmids, was found to suppress phenotypically the S. erythraea eryB25 and eryB26 mutations blocking erythromycin biosynthesis in this organism, probably by the effect of mistranslation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=526855Documentos Relacionados
- Identification of a Saccharopolyspora erythraea gene required for the final hydroxylation step in erythromycin biosynthesis.
- Organization of a cluster of erythromycin genes in Saccharopolyspora erythraea.
- Cloning of genes governing the deoxysugar portion of the erythromycin biosynthesis pathway in Saccharopolyspora erythraea (Streptomyces erythreus).
- Sonication-Dependent Electroporation of the Erythromycin-Producing Bacterium Saccharopolyspora erythraea
- Transcriptional Organization of the Erythromycin Biosynthetic Gene Cluster of Saccharopolyspora erythraea
